Team:EPF Lausanne/Calendar/13 September 2013

From 2013.igem.org

(Difference between revisions)
Line 6: Line 6:
-In order to characterize both the sensing and the effector plasmid I innoculated Bacteria in liquid LB cultures over-night.
-In order to characterize both the sensing and the effector plasmid I innoculated Bacteria in liquid LB cultures over-night.
<BR><BR>
<BR><BR>
-
 
<font size = "4"> Nanoparticles</font> <BR>
<font size = "4"> Nanoparticles</font> <BR>
Line 13: Line 12:
-We Biotinylated the two new nanoparticles batches.
-We Biotinylated the two new nanoparticles batches.
-
''???''<BR>
+
<BR>
-End of the anti-strepta resistance check (sample mix, use of strepatavidin beads and microscopy)
-End of the anti-strepta resistance check (sample mix, use of strepatavidin beads and microscopy)

Revision as of 21:05, 3 October 2013

Taxi.Coli: Smart Drug Delivery iGEM EPFL

Header

Sensing-Effector

Innoculation of Bacteria with our constructs
-In order to characterize both the sensing and the effector plasmid I innoculated Bacteria in liquid LB cultures over-night.

Nanoparticles

Biotinylation
-We Biotinylated the two new nanoparticles batches.


-End of the anti-strepta resistance check (sample mix, use of strepatavidin beads and microscopy)

DSL Measurements
We did DLS measurements of the new biotinylated nanoparticles (before dialysis).